BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6455233)

  • 21. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Horseshoe kidney incidentally detected by 99mTc-MDP bone scintigraphy: report of 2 cases (author's transl)].
    Bussaka H; Takahashi M
    Rinsho Hoshasen; 1982 May; 27(5):581-3. PubMed ID: 6213796
    [No Abstract]   [Full Text] [Related]  

  • 24. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
    Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
    J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexplained transient splenic uptake of Tc-99m MDP in bronchogenic carcinoma.
    Sirotta P; Nelp WB
    Clin Nucl Med; 1984 Sep; 9(9):495-7. PubMed ID: 6237828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cause for visualization of the liver in bone scintigraphy--the effect of the combined use of iron chondroitin sulfate (Blutal)].
    Tanaka S; Sawa H; Fukuda T; Tanaka M; Tsujita Y; Yahata S; Nakajima H; Taniguchi S; Inoue Y; Omura M
    Kaku Igaku; 1983 Sep; 20(8):1175-81. PubMed ID: 6231399
    [No Abstract]   [Full Text] [Related]  

  • 27. Liver uptake and increased renal uptake of Tc-99m HMDP in a patient with iron overload.
    Ohta H
    Clin Nucl Med; 2001 Feb; 26(2):164-5. PubMed ID: 11201486
    [No Abstract]   [Full Text] [Related]  

  • 28. [Extraosseous tumor uptake of 99m-Tc-MDP].
    Hayasaka K; Sugie H; Saitoh Y; Arakawa K; Amoh K
    Rinsho Hoshasen; 1985 Jan; 30(1):61-5. PubMed ID: 3157814
    [No Abstract]   [Full Text] [Related]  

  • 29. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Tc-99m-sodium medronate accumulation in renal carcinoma.
    Polga JP
    Clin Nucl Med; 1981 Sep; 6(9):416-7. PubMed ID: 6456103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tc-99m MDP uptake in the lower extremity. An interesting artifact.
    Massie JD; Mullens R
    Clin Nucl Med; 1983 Sep; 8(9):447. PubMed ID: 6227444
    [No Abstract]   [Full Text] [Related]  

  • 32. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
    Baum RP; Brandhorst I; Maul FD; Hör G
    Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary uptake of Tc-99m-Labeled methylene diphosphonate in a patient with a parathyroid adenoma.
    Herry JY; Chevet D; Moisan A; Le Pogamp P; Le Jeune JJ; Kerdiles Y
    J Nucl Med; 1981 Oct; 22(10):888-90. PubMed ID: 6457136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Four cases of diffuse bone metastasis with increased uptake in 99mTc-MDP bone scintigraphy].
    Dannoura R; Morita S; Kikuchi S; Ohta M; Ohtake H
    Kaku Igaku; 1984 Nov; 21(11):1521-5. PubMed ID: 6241644
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased renal parenchymal accumulation of Tc-99m HDP in kidney contusion.
    Salimi Z; Vas W; Tang-Barton P; Suresh P; Carlin B
    Clin Nucl Med; 1984 Oct; 9(10):574-6. PubMed ID: 6488654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate.
    Smith FW; Gilday DL; Ash JM; Reid RH
    Radiology; 1980 Nov; 137(2):501-4. PubMed ID: 6449027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical comparison of MDP and DMAD.
    Rosenthall L; Stern J; Arzoumanian A
    Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
    Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
    Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.